Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

Prevention of complications in type 2 diabetes mellitus

Bruce H.R. Wolffenbuttel, J—ózef Drzewoski

Med Sci Monit 1999; 5(5): RA1013-1019 :: ID: 503445

Abstract

It is expected that the number of patients suffering from diabetes mellitus will increase in the near future. The high rate of microvascular and macrovascular complications developing in these patients will place an even higher burden on our health care systems. Several pathophysiological factors are involved in the development of complications, among which the hyperglycaemia per se, the consequent formation of advanced glycation end products and the intracellular accumulation of sorbitol. In addition, hypertension and dyslipidaemia also play an important role, especially in the development of coronary heart disease and stroke. The major therapeutic goals in type 2 diabetic patients are to optimize blood glucose control, to reduce overweight and to normalize lipid disturbances and elevated blood pressure, in order to improve the well-being of the patient and reduce the risk for the development of late diabetic complications. The UKPDS has clearly demonstrated that achievement of near-normoglycaemia - with sulfonylurea and/or insulin - can reduce the severity of microvascular complications, and that aggressive lowering of elevated blood pressure - with a beta-blocker or an ACE inhibitor - reduces both micro- and macrovascular complications. Secondary intervention studies have demonstrated the beneficial effects of treatment with beta-blockers, aspirin, and inhibitors of cholesterol synthesis, in diabetic patients after myocardial infarction or with angina pectoris. For coronary revascularisation, a preference for CABG in comparison with PTCA in diabetic patients with coronary multivessel disease was suggested. In addition, aggressive near-normalisation of blood glucose levels in the acute phase of myocardial infarction improves prognosis, and reduces 1-year mortality by 31%.

Keywords: treatment, type 2 diabetic patients, Diabetes Mellitus

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750